Janssen M C, Verbruggen H, Wollersheim H, Hoogkamer B, van Langen H, Nováková I R
Department of Medicine, University Hospital Nijmegen, The Netherlands.
Thromb Haemost. 1997 Aug;78(2):799-802.
A number of studies evaluating deep venous thrombosis (DVT) have demonstrated that plasma levels of thrombotic and fibrinolytic parameters change during treatment, but the relationship between thrombus regression and evolution of these markers remains unknown. The objective of the present study was to correlate levels of D-Dimer (DD) with thrombus regression as assessed by duplex scanning. From 44 patients treated for acute DVT, DD were determined at diagnosis and at the end of initial heparin therapy of at least 5 days. Thrombus regression was measured by repeated duplex scanning at diagnosis and after 1 and 3 months. DD significantly decreased during heparin treatment as compared with values at presentation. DD levels were significantly higher in the group of patients without normalization of the DVT after 3 months (p = 0.003). A ninefold excess tendency was seen for DD levels > 1200 ng/ml at the end of initial treatment to be associated with poor resolution of the DVT [odds ratio 9.0, 0.95 confidence interval (CI) 2.3-35.4]. When the patients with an established malignancy were excluded, the differences were even more significant (p = 0.0004 for DD levels after initial treatment and an odds ratio of 17.5, 0.95 CI 3.3-92.5). These results suggest that increased DD levels after the initial phase of treatment are related to poor resolution of DVT after 3 months. These findings contribute to further insight into the process of thrombus regression. Furthermore high DD levels might help to identify the patients with a poor prognosis and could be useful to judge the efficacy of anticoagulant treatment.
多项评估深静脉血栓形成(DVT)的研究表明,在治疗过程中血栓形成和纤溶参数的血浆水平会发生变化,但这些标志物的血栓消退与演变之间的关系仍不清楚。本研究的目的是将D - 二聚体(DD)水平与通过双功扫描评估的血栓消退情况相关联。对44例急性DVT患者进行研究,在诊断时以及至少5天的初始肝素治疗结束时测定DD。通过在诊断时以及1个月和3个月后重复进行双功扫描来测量血栓消退情况。与就诊时的值相比,肝素治疗期间DD显著降低。3个月后DVT未恢复正常的患者组中DD水平显著更高(p = 0.003)。初始治疗结束时DD水平> 1200 ng/ml的患者出现DVT消退不佳的倾向高出九倍[比值比9.0,95%置信区间(CI)2.3 - 35.4]。当排除已确诊恶性肿瘤的患者时,差异更为显著(初始治疗后DD水平p = 0.0004,比值比为17.5,95% CI 3.3 - 92.5)。这些结果表明,治疗初始阶段后DD水平升高与3个月后DVT消退不佳有关。这些发现有助于进一步深入了解血栓消退过程。此外,高DD水平可能有助于识别预后不良的患者,并可用于判断抗凝治疗的疗效。